• Definition: Inflammatory glomerular disease characterised by:
o Haematuria (often macroscopic)
o Proteinuria (<3.5 g/day)
o Hypertension
o Oliguria ± AKI
o Red cell casts in urine
• Common Causes:
o IgA nephropathy
o Post-streptococcal glomerulonephritis
o Rapidly progressive glomerulonephritis (RPGN)
• Definition: Non-inflammatory glomerular disease with:
o Proteinuria >3.5 g/day
o Oedema
o Hypoalbuminaemia
o Hyperlipidaemia
o Increased risk of thrombosis (especially renal vein) and infection (loss of immunoglobulins)
• Common Causes:
o Children: Minimal change disease (MCD) – excellent steroid response
o Adults:
Membranous nephropathy
Focal segmental glomerulosclerosis (FSGS)
Diabetic nephropathy
Amyloidosis
o Most common primary glomerulonephritis worldwide
o Macroscopic haematuria post-URTI
o Mesangial proliferation + IgA deposition
o Normal or mildly ↓ complement levels
o May progress to CKD; ACEi for proteinuria, steroids in select cases
o Typically in children/young adults ~2 weeks after streptococcal pharyngitis/impetigo
o Features: haematuria (cola-coloured urine), oedema, HTN
o Investigations: ↓ C3, ↑ anti-streptolysin O (ASO)
o Self-limiting; supportive treatment
o Medical emergency with rapid loss of renal function
o Histology: crescent formation
o Causes:
Goodpasture’s syndrome: anti-GBM antibodies → GN + pulmonary haemorrhage
ANCA-associated vasculitis:
GPA (Wegener’s): c-ANCA (PR3), ENT/lung/kidney
MPA: p-ANCA (MPO), lung + kidney
o Treatment: high-dose steroids + cyclophosphamide ± plasmapheresis
o Segmental sclerosis in parts of glomeruli
o Common cause of nephrotic syndrome in Black adults
o Secondary causes: HIV, heroin, obesity, sickle cell
o Often steroid-resistant; may progress to ESRD
o Commonest nephrotic syndrome in children
o Normal light microscopy; effacement of foot processes on EM
o Excellent response to steroids
o Relapse common; may be triggered by infections/allergens
o Common cause of nephrotic syndrome in Caucasian adults
o Pathology: subepithelial immune complex deposits
o Associated with:
Primary: anti-PLA2R antibodies
Secondary: malignancy, HBV, SLE, NSAIDs
o High risk of renal vein thrombosis
o Tram-track appearance on LM (due to mesangial and basement membrane proliferation)
o Associated with hepatitis C, cryoglobulinaemia, complement dysregulation
o Low C3 due to persistent activation of complement
o X-linked defect in type IV collagen
o Features: haematuria, sensorineural deafness, anterior lenticonus
o Family history often positive
o Benign familial haematuria
o Good prognosis; normal renal function
————————————————————————————————————————————————————————————————————————————————————————————————————————-
Author & Educational Disclaimer
Author:
Dr Phillip Cockrell BM FRCP DipClinEd
Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.
He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.
Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.
Purpose of this content:
The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.
Medical disclaimer:
This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.